Physician profile
Jack Kendrick
NPI 1255489415
$1,233.06
in general payments reported to CMS, 2019-2025
21 companies · $97.14 in 2025
The $97.14 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $210 · 2021: $53.86 · 2022: $127 · 2023: $200 · 2024: $114 · 2025: $97.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $343.86 | 2019-2022 | |
| Abbvie INC. | $151.09 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.89 | 2019-2023 | Xifaxan |
| Lilly USA, LLC | $79.11 | 2019-2024 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $72.79 | 2023-2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $69.99 | 2019 | |
| Novo Nordisk INC | $63.63 | 2019-2023 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $62.21 | 2021-2022 | |
| Astellas Pharma US INC | $47.47 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $45.77 | 2019 | |
| Pfizer INC. | $35.29 | 2019 | |
| Allergan, INC. | $27.79 | 2020 | |
| Vanda Pharmaceuticals INC. | $26.63 | 2025 | Hetlioz, Fanapt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.77 | 2023 | Lifevest |
| Nestle Healthcare Nutrition INC. | $16.73 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $16.71 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.05 | 2024 | Nuzyra |
| Ibsa Pharma INC. | $15.86 | 2025 | Tirosint, Licart, Flector |
| Glaxosmithkline, LLC. | $15.60 | 2025 | Arexvy, Shingrix |
| Bioxcel Therapeutics, INC. | $15.29 | 2023 | Igalmi |
| Corcept Therapeutics | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Kendrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.